- 全部删除
- 您的购物车当前为空
Seratrodast (ABT-001) 是一种血栓素 A2 受体 (TP) 拮抗剂,用于治疗哮喘。
为众多的药物研发团队赋能,
让新药发现更简单!
Seratrodast (ABT-001) 是一种血栓素 A2 受体 (TP) 拮抗剂,用于治疗哮喘。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
5 mg | ¥ 255 | In stock | |
10 mg | ¥ 413 | In stock | |
25 mg | ¥ 637 | In stock | |
50 mg | ¥ 828 | In stock | |
100 mg | ¥ 1,370 | In stock | |
200 mg | ¥ 2,080 | In stock | |
500 mg | ¥ 3,530 | In stock | |
1 mL x 10 mM (in DMSO) | ¥ 327 | In stock |
Seratrodast 相关产品
产品描述 | Seratrodast (ABT-001) (INN), a thromboxane A2 (TXA2) receptor (TP receptor) antagonist, is mainly used in the therapy of asthma. It was the first TP receptor antagonist developed as an anti-asthmatic drug and attained marketing qualification in Japan in 1997. |
别名 | 塞曲司特, ABT-001, AA 2414 |
分子量 | 354.44 |
分子式 | C22H26O4 |
CAS No. | 112665-43-7 |
Smiles | C(CCCCCC(O)=O)(C1=C(C)C(=O)C(C)=C(C)C1=O)C2=CC=CC=C2 |
密度 | 1.14 g/cm3 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 50 mg/mL (141.07 mM), Sonication is recommended. ![]() | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
|
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
评论内容